Biomarkers of systemic inflammation provide additional prognostic stratification in cancers of unknown primary.
Journal Information
Full Title: Cancer Med
Abbreviation: Cancer Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Evidence found in paper:
"data s1."
Code Sharing
COI Disclosure
Evidence found in paper:
"CONFLICT OF INTEREST STATEMENT NC—outside the scope of the work presented, research funding/educational research grants have been received by the Experimental Cancer Medicine Team (PI: Cook) from AstraZeneca, Bayer, Pfizer, Orion, Taiho Oncology, Roche, Starpharma, Eisai, RedX, UCB, Boeringher, Merck, Stemline Tarveda and Avacta. The remaining authors have no conflicts to declare."
Funding Disclosure
Evidence found in paper:
"FUNDING INFORMATION This work was supported by the University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Edinburgh, UK."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025